Qixun Chen

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 144 citations · Full text

Surgical Oncology, Esophageal Cancer, Neoadjuvant Therapy +16

Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer

Ying Jin, Yamei Chen, Huarong Tang et al. · Clinical Cancer Research · 2021 · 105 citations · Full text

The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma

D. S. Shen, Qixun Chen, Jie Wu et al. · Journal of Gastrointestinal Oncology · 2021 · 95 citations · Full text

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 87 citations

Surgical Oncology, Interim Event-free Survival, Placebo Arm +15

Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma

Ji Feng, Qixun Chen · Therapeutics and Clinical Risk Management · 2013 · 81 citations · Full text